Skip to Main Content

Paper Details

Oral Nirmatrelvir and Ritonavir for Coronavirus Disease 2019 in Vaccinated, Nonhospitalized Adults Aged 18-50 Years.
Clin Infect Dis
6
2023
COPD, COVID-19, COVID-19 illness, Coronavirus Disease, NMV, Nirmatrelvir, Patients, Ritonavir, asthma, cancer, cardiovascular disease, chronic lower respiratory, chronic lower respiratory disorders, chronic obstructive pulmonary disease, coronavirus disease 2019, nirmatrelvir, patients, person, ritonavir
Author NameAffiliation
Sourbha S DaniLahey Hospital and Medical Center
Paul E SaxBrigham and Women's Hospital and Harvard Medical School
  • 1 - 2

Datasets

Release 1.2